Drawing for ORAPLATIN

USPTO serial 76512746

ORAPLATIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROSSMAN, MARY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ORAPLATIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven R. Lazar

AGNES S LEE ESQ TRADEMARK DOCKETING SPECIALISTROPES & GRAY LLPONE INTERNATIONAL PLBOSTON, MA 02110-2624

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of human diseases and disorders, namely, oncologic and cell proliferative diseases or disordersACTIVE—
042Scientific research; medical research; industrial research and contract research services for others in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology, and chemical, biochemical and biotechnological analysis; computer software design for others in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology, and chemical, biochemical and biotechnological analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 4, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 4, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 3, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 25, 2004ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Oct 18, 2004MAILPAPER RECEIVED—
Aug 31, 2004ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 27, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 7, 2004NPUBNOTICE OF PUBLICATION—
May 13, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 2004CNEAEXAMINERS AMENDMENT MAILED—
Apr 26, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 26, 2004MAILPAPER RECEIVED—
Nov 18, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 23, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance